PubRank

P Morgan-Capner

Author PubWeight™ 115.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) 1980 4.13
2 A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995 3.93
3 Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ 1989 2.48
4 The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev 1994 2.32
5 The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000 2.25
6 A rationalised virological electron microscope specimen testing policy. PHLS North West Viral Gastroenteritis and Electron Microscopy Subcommittee. J Clin Pathol 1999 2.09
7 Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet 1985 2.08
8 Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol 1996 1.90
9 Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 1995 1.89
10 A comparison of three tests for rubella antibody screening. J Clin Pathol 1979 1.71
11 Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol 1993 1.66
12 Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol 2000 1.55
13 Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect 1995 1.50
14 Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) 1983 1.45
15 Rash in early pregnancy. Br Med J (Clin Res Ed) 1983 1.43
16 Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 1988 1.43
17 Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect 1994 1.43
18 Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev 1997 1.40
19 Rubella-specific IgM detection using Sephacryl S-300 gel filtration. J Clin Pathol 1980 1.36
20 End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 1989 1.36
21 Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 2006 1.34
22 Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods 1992 1.32
23 Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 1994 1.32
24 Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 2004 1.26
25 Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol 1999 1.26
26 Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM. J Hyg (Lond) 1983 1.25
27 Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 2002 1.24
28 The role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay. J Hosp Infect 1998 1.22
29 A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgM. J Virol Methods 1984 1.21
30 Specific IgG subclass antibody in rubella virus infections. Epidemiol Infect 1988 1.20
31 An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J Virol Methods 1997 1.17
32 The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect 1999 1.14
33 Serological study of the epidemiology of mumps virus infection in north-west England. Epidemiol Infect 1990 1.13
34 A trial of povidone iodine dry powder spray for the prevention of infusion thrombophlebitis. J Hosp Infect 1980 1.12
35 The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiol Infect 2002 1.11
36 The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 1997 1.10
37 Human parvovirus and rubella-like illness. Lancet 1985 1.10
38 Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev 2002 1.09
39 The risk of acquiring Q fever on farms: a seroepidemiological study. Occup Environ Med 1995 1.06
40 The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 2000 1.05
41 Zoonotic illness--determining risks and measuring effects: association between current animal exposure and a history of illness in a well characterised rural population in the UK. J Epidemiol Community Health 1994 1.05
42 Mental health of British farmers. Occup Environ Med 2003 1.04
43 The seroepidemiology of measles in Western Europe. Epidemiol Infect 2001 1.04
44 Persistent rubella-specific IgM reactivity in the absence of recent primary rubella and rubella reinfection. J Med Virol 1992 1.03
45 Fetoscopy in the assessment of unexplained fetal hydrops. Br J Obstet Gynaecol 1985 1.03
46 Serological distinction between primary rubella and reinfection. Lancet 1988 1.02
47 The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect 2002 1.01
48 Rubella-specific IgG1 avidity: a comparison of methods. J Virol Methods 1991 1.01
49 Immunity to diphtheria in adults in England. BMJ 1994 1.00
50 The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun Dis Rep CDR Rev 1997 0.99
51 Prenatal detection of rubella-specific IgM in fetal sera. Prenat Diagn 1985 0.99
52 Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J 1984 0.99
53 Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev 1994 0.99
54 Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 1993 0.98
55 Nature of circulating immune complexes in infective endocarditis. J Clin Pathol 1980 0.97
56 The prevalence of hepatitis C in England and Wales. J Infect 2002 0.96
57 Evaluation of a commercial antibody capture enzyme immunoassay for the detection of rubella specific IgM. J Clin Pathol 1984 0.96
58 Evaluation of 15 commercial enzyme immunoassays for the detection of rubella-specific IgM. Clin Diagn Virol 1996 0.94
59 Prenatal diagnosis of rubella. Lancet 1984 0.94
60 Clinically apparent rubella reinfection with a detectable rubella specific IgM response. Br Med J (Clin Res Ed) 1983 0.93
61 Reactivity for rubella-specific IgM in sera from patients with infectious mononucleosis. Lancet 1983 0.92
62 The detection of rubella-specific IgM by an immunosorbent assay with solid-phase attachment of red cells (SPARC). J Hyg (Lond) 1982 0.92
63 Endomyocardial biopsy and viral heart disease. Verh Dtsch Ges Herz Kreislaufforsch 1983 0.90
64 Transmission of HIV-1 infection after a fight. Lancet 1992 0.88
65 Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 1995 0.88
66 Importance of markers of hepatitis B virus in alcoholic liver disease. Br Med J (Clin Res Ed) 1983 0.88
67 Characterization of enterovirus isolates from patients with heart muscle disease in a selenium-deficient area of China. J Clin Microbiol 2000 0.87
68 Prenatal serological diagnosis of intrauterine cytomegalovirus infection. Br Med J (Clin Res Ed) 1982 0.87
69 Chlamydial screening of pregnant women in a sexually transmitted diseases clinic. Br J Vener Dis 1982 0.87
70 Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain. Am J Pathol 1997 0.86
71 A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model. Arch Virol 1995 0.86
72 Further investigation of the specificity and sensitivity of ELISA for rubella antibody screening. J Clin Pathol 1980 0.86
73 Rubella-specific IgG subclass concentrations in sera using an enzyme-linked immunosorbent assay (ELISA): the effect of different sources of rubella antigen. Epidemiol Infect 1988 0.86
74 Radial haemolysis for the detection of rubella antibody in acute postnatal rubella. J Hyg (Lond) 1982 0.85
75 The avidity of specific IgM detected in primary rubella and reinfection. Epidemiol Infect 1990 0.85
76 Joint symptoms, immune complexes, and rubella. Lancet 1980 0.84
77 Low rates of ehrlichiosis and Lyme borreliosis in English farmworkers. Epidemiol Infect 1998 0.83
78 Outcome of pregnancy after maternal reinfection with rubella. CDR (Lond Engl Rev) 1991 0.83
79 False positive tests for rubella-specific IgM. Pediatr Infect Dis J 1991 0.83
80 Chlamydial antibodies in farmers in north-west England. Epidemiol Infect 1988 0.83
81 Measles antibody in Paget's disease. Lancet 1981 0.82
82 Clinically apparent rubella reinfection. J Infect 1984 0.82
83 A fatal case of Epstein-Barr virus infection with jaundice and renal failure. Postgrad Med J 1980 0.82
84 Orf (contagious pustular dermatitis) in farmworkers: prevalence and risk factors in three areas of England. Vet Rec 1999 0.82
85 Myocarditis and fulminant hepatic failure from coxsackievirus B infection. Postgrad Med J 1985 0.82
86 Immunity to viral infections among medical students in London. BMJ 1994 0.81
87 Borna disease virus and mental health: a cross-sectional study. QJM 2005 0.80
88 Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England. Eur J Epidemiol 2000 0.80
89 Renal medullary haemorrhage and echovirus infection. Lancet 1980 0.79
90 Diphtheria immunity in adults. Lancet 1996 0.78
91 Detection of Chlamydia trachomatis by enzyme immunoassay, immunofluorescence, and cell culture. J Clin Pathol 1986 0.78
92 Zoonotic and viral infection in fetal loss after 12 weeks. Br J Obstet Gynaecol 1997 0.78
93 Recommendations of the 7th European Meeting of Influenza and Its Prevention. Eur J Epidemiol 1994 0.76
94 HIV and insurance. BMJ 1993 0.75
95 Infant chlamydial pneumonia. Br Med J (Clin Res Ed) 1983 0.75
96 Public Health Laboratory Service IgM antibody capture enzyme linked immunosorbent assay for detecting rubella specific IgM. J Clin Pathol 1985 0.75
97 Laboratory diagnosis and clinical significance of rubella in children with cancer. Epidemiol Infect 1989 0.75
98 Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection. J Clin Pathol 1986 0.75
99 Fungal endocarditis in a patient with acute leukaemia treated by valve replacement. Br Med J (Clin Res Ed) 1982 0.75
100 Isolation of Chlamydia trachomatis from prostatic fluid in association with inflammatory joint or eye disease. Br J Vener Dis 1983 0.75
101 Cowpox virus. Br J Ophthalmol 1993 0.75
102 Sex ratio in outbreaks of parvovirus B19 infection. Lancet 1987 0.75
103 Potential hazards with fine bore capillary tubes used by non-pathology staff. J Hosp Infect 1994 0.75
104 Cranial-nerve involvement in herpes zoster. Lancet 1979 0.75
105 [Prenatal diagnosis of congenital rubella]. Ugeskr Laeger 1985 0.75
106 Hepatitis B vaccine for health care personnel. J Hosp Infect 1983 0.75
107 How sensitive are the commercial assays for anti-HTLV III/LAV? J Med Virol 1987 0.75
108 Clinical rubella reinfection--a case of arthropathy. J Infect 1991 0.75
109 Problems in management of health care workers exposed to HBeAg positive body fluids. J Hosp Infect 1994 0.75
110 Rubella screening. Lancet 1983 0.75
111 Consensus on HIV testing. BMJ 1988 0.75
112 Rubella vaccination policy: a note of reassurance. Lancet 1987 0.75
113 Fetal and neonatal infection. Nurs Times 1985 0.75
114 Severe chickenpox in anabolic steroid user. Lancet 1995 0.75
115 Childhood infection with hepatitis A and B viruses in England and Wales. Commun Dis Rep CDR Rev 1997 0.75
116 Radial haemolysis for rubella antibody screening. Lancet 1979 0.75